Faculty Profiles - ANDO Yuichi

Papers - ANDO Yuichi

Division display 21 - 40 of about 124 ／ All the affair displays >>

Durvalumab plus carboplatin-etoposide treatment in a patient with small-cell lung cancer on hemodialysis: a case report and literature review

Ushijima, F; Hase, T; Yamashita, Y; Kim, H; Shimokata, T; Kondo, C; Sato, T; Baba, T; Watanabe, S; Futamura, K; Ando, Y; Mizuno, M; Ishii, M

INTERNATIONAL CANCER CONFERENCE JOURNAL Vol. 13 ( 2 ) page： 88 - 92 2024.4

Efficacy and Safety of Anti-angiogenic Agents for Cancer Patients With Proteinuria or a History of Proteinuria: A Systematic Review

Kato, T; Kurasawa, S; Takezawa, K; Fujiwara, Y; Yasuda, Y; Ando, Y

ANTICANCER RESEARCH Vol. 44 ( 3 ) page： 889 - 894 2024.3

Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer

Liang, Y; Maeda, O; Miyata, K; Kanda, M; Sugita, S; Shimizu, D; Nishida, K; Kodera, Y; Ando, Y

CANCER CHEMOTHERAPY AND PHARMACOLOGY Vol. 93 ( 2 ) page： 121 - 127 2024.2

Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 (oct, 10.1007/s10157-023-02415-0, 2022)

Yanagita, M; Muto, S; Nishiyama, H; Ando, Y; Hirata, S; Doi, K; Fujiwara, Y; Hanafusa, N; Hatta, T; Hoshino, J; Ichioka, S; Inoue, T; Ishikura, K; Kato, T; Kitamura, H; Kobayashi, Y; Koizumi, Y; Kondoh, C; Matsubara, T; Matsubara, K; Matsumoto, K; Okuda, Y; Okumura, Y; Sakaida, E; Shibagaki, Y; Shimodaira, H; Takano, N; Uchida, A; Yakushijin, K; Yamamoto, T; Yamamoto, K; Yasuda, Y; Oya, M; Okada, H; Nangaku, M; Kashihara, N

CLINICAL AND EXPERIMENTAL NEPHROLOGY Vol. 28 ( 2 ) page： 123 - 124 2024.2

Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022

CLINICAL AND EXPERIMENTAL NEPHROLOGY Vol. 28 ( 2 ) page： 85 - 122 2024.2

Protocol of a phase II study investigating the efficacy and safety of trifluridine/tipiracil plus ramucirumab as a third-line or later treatment for advanced gastric cancer

Nakanishi, K; Tanaka, C; Kanda, M; Miyata, K; Machida, N; Sakai, M; Kobayashi, D; Teramoto, H; Ishiyama, A; Sato, B; Oshima, T; Kajikawa, M; Matsushita, H; Ishigure, K; Yamashita, K; Fujitake, S; Sueoka, S; Asada, T; Shimizu, D; Sugita, S; Kuwatsuka, Y; Maeda, O; Furune, S; Murotani, K; Ando, Y; Ebata, T; Kodera, Y

NAGOYA JOURNAL OF MEDICAL SCIENCE Vol. 86 ( 1 ) page： 43 - 51 2024.2

Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors

Liang, Y; Maeda, O; Ando, Y

JAPANESE JOURNAL OF CLINICAL ONCOLOGY Vol. 54 ( 4 ) page： 365 - 375 2024.1

Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer

Maeda, O; Furune, S; Kanda, M; Miyata, K; Shimizu, D; Sugita, S; Nishida, K; Ando, M; Kodera, Y; Ando, Y

CANCER MEDICINE Vol. 13 ( 2 ) page： e6974 2024.1

Potential drug interactions between pazopanib and proton pump inhibitors/potassium-competitive acid blockers in patients with soft tissue sarcoma

Liang, Y; Maeda, O; Shimokata, T; Yokota, K; Koike, H; Sakai, T; Ikuta, K; Urakawa, H; Nishida, Y; Akiyama, M; Ando, Y

INTERNATIONAL CANCER CONFERENCE JOURNAL Vol. 13 ( 1 ) page： 63 - 67 2024.1

Comment on: Carboplatin and irinotecan (CI) vs. Carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial

Furune, S; Ando, Y

LUNG CANCER Vol. 186 page： 107416 2023.12

Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer

Nakanishi, K; Tanaka, C; Kanda, M; Miyata, K; Furukawa, K; Maeda, O; Shimizu, D; Sugita, S; Kakushima, N; Furune, S; Kawashima, H; Ando, Y; Ebata, T; Kodera, Y

CANCERS Vol. 15 ( 21 ) 2023.11

Adjustment of creatinine clearance for carboplatin dosing in Calvert's formula and clinical efficacy for lung cancer

Hatta, T; Hase, T; Hara, T; Kimura, T; Kojima, E; Abe, T; Horio, Y; Goto, Y; Ozawa, N; Yogo, N; Shibata, H; Shimokata, T; Oguri, T; Yamamoto, M; Yanagisawa, K; Ando, M; Ando, Y; Kondo, M; Ishii, M; Hasegawa, Y

CANCER MEDICINE Vol. 12 ( 15 ) page： 15955 - 15969 2023.8

Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis

Yamamoto, T; Mizuno, K; Ito, T; Yokoyama, S; Yamamoto, K; Imai, N; Ishizu, Y; Honda, T; Ishikawa, T; Kanamori, A; Yasuda, S; Toyoda, H; Yokota, K; Hase, T; Nishio, N; Maeda, O; Ishii, M; Sone, M; Ando, Y; Akiyama, M; Ishigami, M; Kawashima, H

INVESTIGATIONAL NEW DRUGS Vol. 41 ( 3 ) page： 512 - 521 2023.6

Feasibility assessment of global standard chemoradiotherapy followed by surgery in patients with esophageal cancer

Liang, Y; Maeda, O; Miyata, K; Kanda, M; Shimizu, D; Sugita, S; Okada, T; Ito, J; Kawamura, M; Ishihara, S; Nakatochi, M; Ando, M; Kodera, Y; Ando, Y

MOLECULAR AND CLINICAL ONCOLOGY Vol. 18 ( 4 ) page： 34 2023.4

Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury

Yamamoto, T; Morooka, H; Ito, T; Ishigami, M; Mizuno, K; Yokoyama, S; Yamamoto, K; Imai, N; Ishizu, Y; Honda, T; Yokota, K; Hase, T; Maeda, O; Hashimoto, N; Ando, Y; Akiyama, M; Kawashima, H

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 38 ( 2 ) page： 251 - 258 2023.2

Preoperative docetaxel, cisplatin, and fluorouracil treatment with pegfilgrastim on day 7 for patients with esophageal cancer: A phase II study

Maeda, O; Fukaya, M; Koike, M; Miyata, K; Kanda, M; Nishida, K; Ando, M; Kodera, Y; Ando, Y

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 18 ( 6 ) page： 578 - 585 2022.12

Selection of chemotherapy for older patients with pancreatic cancer based on geriatric assessment

Maeda, O; Matsuoka, A; Yanagawa, M; Muroyama, Y; Watanabe, K; Liang, Y; Ishikawa, T; Ohno, E; Kawashima, H; Umegaki, H; Kuzuya, M; Ando, Y

JOURNAL OF GERIATRIC ONCOLOGY Vol. 13 ( 8 ) page： 1260 - 1263 2022.11

A phase I study of LCL161, a novel oral pan-inhibitor of apoptosis protein (IAP) antagonist, in Japanese patients with advanced solid tumors

Morita, S; Minami, H; Mitsuma, A; Toyoda, M; Kiyota, N; Ando, Y

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 18 ( 5 ) page： E427 - E434 2022.10

Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade

Kobayashi, T; Iwama, S; Yamagami, A; Yasuda, Y; Okuji, T; Ito, M; Zhou, X; Ando, M; Onoue, T; Miyata, T; Sugiyama, M; Hagiwara, D; Suga, H; Banno, R; Hase, T; Morise, M; Ito, T; Kikumori, T; Inoue, M; Ando, Y; Masuda, N; Kawashima, H; Hashimoto, N; Arima, H

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM Vol. 107 ( 10 ) page： E4115 - E4123 2022.9

Summary of the Clinical Practice Guidelines for Penile Cancer 2021 by the Japanese Urological Association

Yamaguchi, T; Sugiyama, Y; Tanaka, T; Kimura, T; Yumura, Y; Nakano, M; Sugiyama, T; Miura, N; Goya, M; Yamamoto, A; Takahashi, S; Miura, Y; Tsuzuki, T; Masumori, N; Nishiyama, H; Yao, MS; Koie, T; Miyake, H; Saika, T; Saito, S; Akimoto, T; Tamada, T; Ando, Y; Takahashi, S; Suzuki, T; Hinotsu, S; Kamba, T

INTERNATIONAL JOURNAL OF UROLOGY Vol. 29 ( 8 ) page： 780 - 792 2022.8

　 PREV - NEXT 　

<ANDO Yuichi>

Papers - ANDO Yuichi